Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 17 | 2024 | 451 | 4.540 |
Why?
|
| Lung Diseases, Interstitial | 18 | 2024 | 807 | 4.380 |
Why?
|
| Scleroderma, Systemic | 9 | 2024 | 313 | 2.370 |
Why?
|
| Pulmonary Fibrosis | 6 | 2023 | 526 | 1.590 |
Why?
|
| Collagen Type I | 3 | 2023 | 592 | 1.300 |
Why?
|
| Molecular Imaging | 5 | 2023 | 831 | 1.130 |
Why?
|
| Gallium Radioisotopes | 3 | 2023 | 178 | 1.050 |
Why?
|
| Continuous Positive Airway Pressure | 6 | 2014 | 546 | 0.900 |
Why?
|
| Lung | 20 | 2024 | 9826 | 0.870 |
Why?
|
| Fibrosis | 8 | 2023 | 2026 | 0.710 |
Why?
|
| Sleep Apnea, Obstructive | 5 | 2014 | 1808 | 0.620 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 381 | 0.580 |
Why?
|
| Dyspnea | 4 | 2024 | 1298 | 0.530 |
Why?
|
| Autoantibodies | 3 | 2020 | 2036 | 0.510 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2016 | 193 | 0.510 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 665 | 0.480 |
Why?
|
| Collagen | 2 | 2023 | 2684 | 0.460 |
Why?
|
| Gadolinium | 1 | 2018 | 951 | 0.440 |
Why?
|
| Lysophospholipids | 2 | 2022 | 331 | 0.440 |
Why?
|
| Sleep Apnea, Central | 1 | 2013 | 84 | 0.440 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 6259 | 0.390 |
Why?
|
| Masks | 1 | 2013 | 195 | 0.390 |
Why?
|
| Pneumonia | 1 | 2023 | 2117 | 0.380 |
Why?
|
| Vascular Diseases | 1 | 2018 | 1155 | 0.350 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1527 | 0.350 |
Why?
|
| Biomedical Research | 1 | 2024 | 3306 | 0.320 |
Why?
|
| Capillary Permeability | 2 | 2022 | 798 | 0.300 |
Why?
|
| Autoantigens | 2 | 2020 | 891 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 35342 | 0.240 |
Why?
|
| Humans | 54 | 2024 | 742088 | 0.240 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2023 | 19 | 0.240 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 314 | 0.210 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Models, Biological | 1 | 2019 | 9581 | 0.210 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13019 | 0.210 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2023 | 218 | 0.170 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 608 | 0.170 |
Why?
|
| Research Subjects | 1 | 2021 | 238 | 0.170 |
Why?
|
| Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2022 | 2335 | 0.160 |
Why?
|
| Critical Care | 2 | 2021 | 2640 | 0.160 |
Why?
|
| Ephrin-B2 | 1 | 2017 | 39 | 0.160 |
Why?
|
| Indoles | 2 | 2024 | 1834 | 0.150 |
Why?
|
| Blood Pressure | 2 | 2014 | 8541 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2021 | 20086 | 0.150 |
Why?
|
| Receptors, Chemokine | 1 | 2021 | 669 | 0.150 |
Why?
|
| Radiometry | 1 | 2022 | 800 | 0.150 |
Why?
|
| Molecular Probes | 1 | 2018 | 316 | 0.140 |
Why?
|
| Lung Diseases | 2 | 2019 | 1884 | 0.140 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15530 | 0.140 |
Why?
|
| Galectin 3 | 1 | 2018 | 227 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4379 | 0.140 |
Why?
|
| Radiation Injuries | 1 | 2023 | 1178 | 0.140 |
Why?
|
| Sepsis | 2 | 2021 | 2589 | 0.140 |
Why?
|
| Myofibroblasts | 1 | 2017 | 221 | 0.130 |
Why?
|
| Biopsy | 3 | 2022 | 6756 | 0.130 |
Why?
|
| Bronchiectasis | 1 | 2016 | 128 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2018 | 592 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2023 | 4143 | 0.120 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2014 | 17 | 0.120 |
Why?
|
| Immunosuppressive Agents | 5 | 2024 | 4147 | 0.120 |
Why?
|
| Cyclophosphamide | 3 | 2024 | 2236 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2017 | 584 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 1640 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 1263 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1820 | 0.110 |
Why?
|
| Breath Tests | 1 | 2014 | 276 | 0.110 |
Why?
|
| Prone Position | 1 | 2014 | 194 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2019 | 773 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 21719 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3455 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 1199 | 0.100 |
Why?
|
| Female | 17 | 2022 | 379592 | 0.100 |
Why?
|
| Male | 17 | 2022 | 349538 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 9941 | 0.100 |
Why?
|
| Tidal Volume | 1 | 2014 | 489 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 959 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1741 | 0.100 |
Why?
|
| Patient Positioning | 1 | 2014 | 322 | 0.100 |
Why?
|
| Critical Illness | 2 | 2021 | 2665 | 0.100 |
Why?
|
| Aged | 10 | 2021 | 162944 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1477 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1625 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2020 | 4024 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2187 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2017 | 1065 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 2014 | 671 | 0.080 |
Why?
|
| Prognosis | 3 | 2023 | 29010 | 0.080 |
Why?
|
| Middle Aged | 11 | 2021 | 213127 | 0.080 |
Why?
|
| Contrast Media | 2 | 2020 | 5295 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57683 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2024 | 77098 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 7276 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1155 | 0.080 |
Why?
|
| Disease Progression | 4 | 2024 | 13256 | 0.070 |
Why?
|
| Polysomnography | 1 | 2013 | 1772 | 0.070 |
Why?
|
| United States | 3 | 2024 | 69693 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2019 | 3679 | 0.070 |
Why?
|
| Quality of Life | 5 | 2024 | 12730 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12958 | 0.060 |
Why?
|
| Risk Factors | 3 | 2024 | 72145 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 940 | 0.060 |
Why?
|
| Skin | 1 | 2017 | 4353 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9715 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2023 | 120 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 2566 | 0.050 |
Why?
|
| Heart Rate | 1 | 2014 | 4091 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 298 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2024 | 343 | 0.050 |
Why?
|
| Animals | 7 | 2023 | 168561 | 0.050 |
Why?
|
| Vital Capacity | 1 | 2024 | 922 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 286 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 499 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7873 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 568 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2021 | 194 | 0.040 |
Why?
|
| Therapeutic Equipoise | 1 | 2019 | 28 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 32 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 30 | 0.040 |
Why?
|
| Peroxidase | 1 | 2023 | 610 | 0.040 |
Why?
|
| Sphingosine | 1 | 2022 | 307 | 0.040 |
Why?
|
| Exoribonucleases | 1 | 2019 | 95 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 116 | 0.040 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2019 | 61 | 0.040 |
Why?
|
| Mucin-5B | 1 | 2019 | 141 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 56350 | 0.040 |
Why?
|
| Immunosorbent Techniques | 1 | 2018 | 184 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2013 | 6142 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2020 | 62966 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39004 | 0.040 |
Why?
|
| Mice | 5 | 2023 | 81045 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 521 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2019 | 155 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 844 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 4554 | 0.040 |
Why?
|
| Adult | 6 | 2021 | 213712 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 40450 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 391 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 559 | 0.030 |
Why?
|
| Exocytosis | 1 | 2017 | 353 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 497 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19862 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1126 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2021 | 2295 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 10856 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2019 | 592 | 0.030 |
Why?
|
| Observer Variation | 1 | 2021 | 2593 | 0.030 |
Why?
|
| Resuscitation | 1 | 2019 | 657 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 2006 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2018 | 880 | 0.030 |
Why?
|
| Pyridones | 1 | 2019 | 712 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 729 | 0.030 |
Why?
|
| Integrins | 1 | 2018 | 845 | 0.030 |
Why?
|
| Hypertension | 1 | 2014 | 8455 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 861 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2022 | 2751 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2019 | 503 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2024 | 53187 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18006 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1107 | 0.030 |
Why?
|
| Supine Position | 1 | 2014 | 204 | 0.030 |
Why?
|
| Respiration | 1 | 2020 | 1645 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3164 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 8925 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 1460 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 21821 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 1988 | 0.030 |
Why?
|
| Vaccination | 1 | 2023 | 3256 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2183 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14720 | 0.020 |
Why?
|
| Artifacts | 1 | 2020 | 1903 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4438 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9735 | 0.020 |
Why?
|
| RNA | 1 | 2019 | 2747 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2021 | 3740 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2022 | 5019 | 0.020 |
Why?
|
| Remission Induction | 1 | 2014 | 2384 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6608 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4801 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5519 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2019 | 4983 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4029 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15056 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7901 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 7141 | 0.020 |
Why?
|
| Logistic Models | 1 | 2019 | 13403 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16331 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2019 | 6540 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14554 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10472 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8621 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9846 | 0.010 |
Why?
|
| Obesity | 2 | 2014 | 12705 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8297 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2014 | 6440 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12220 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3038 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17400 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 85649 | 0.000 |
Why?
|
| Neoplasms | 1 | 2013 | 21596 | 0.000 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_